Quinolones

被引:18
作者
Alós, JI [1 ]
机构
[1] Hosp Mostoles, Microbiol Serv, Madrid 28935, Spain
来源
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2003年 / 21卷 / 05期
关键词
quinolones; fluoroquinolones; antimicrobial agents; review;
D O I
10.1157/13046545
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Ouinolones act by inhibiting enzymes (topoisomerases), which are indispensable to DNA synthesis. Their bactericidal activity is concentration-dependent. Their spectrum has become broader, especially since the introduction of a fluorine atom at position 6 (fluoroquinolones). They are used as the treatment of choice or as alternative therapy in a wide variety of infections, both in the hospital and non-hospital setting. Depending on the compound, they are used in urinary tract infections, sexually transmitted diseases, chronic osteomyelitis, respiratory tract infections, and severe systemic infections, among others. The upsurge and extent of quinolone resistance has limited the use of these agents in some cases and in future may determine their use in others. There are strategies to minimize the spread of resistance. Quinolones are safe and well tolerated. The most frequent adverse effects are gastrointestinal and those affecting the central nervous system.
引用
收藏
页码:261 / 268
页数:8
相关论文
共 59 条
  • [41] Quinolone molecular structure-activity relationships: What we have learned about improving antimicrobial activity
    Peterson, LR
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 : S180 - S186
  • [42] Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults
    Petitpretz, P
    Arvis, P
    Marel, M
    Moita, J
    Urueta, J
    [J]. CHEST, 2001, 119 (01) : 185 - 195
  • [43] Evidence for an efflux pump mediating multiple antibiotic resistance in Salmonella enterica serovar Typhimurium
    Piddock, LJV
    White, DG
    Gensberg, K
    Pumbwe, L
    Griggs, DJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (11) : 3118 - 3121
  • [44] Antimicrobial susceptibility of Neisseria gonorrhoeae isolated in Bangladesh (1997 to 1999):: Rapid shift to fluoroquinolone resistance
    Rahman, M
    Sultan, Z
    Monira, S
    Alam, A
    Nessa, K
    Islam, S
    Nahar, S
    Shama-A-Waris
    Khan, SA
    Bogaerts, J
    Islam, N
    Albert, J
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (06) : 2037 - 2040
  • [45] Antimicrobial therapy for chronic osteomyelitis in adults: Role of the quinolones
    Rissing, JP
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 25 (06) : 1327 - 1333
  • [46] EVOLUTION OF SUSCEPTIBILITIES OF CAMPYLOBACTER SPP TO QUINOLONES AND MACROLIDES
    SANCHEZ, R
    FERNANDEZBACA, V
    DIAZ, MD
    MUNOZ, P
    RODRIGUEZCREIXEMS, M
    BOUZA, E
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (09) : 1879 - 1882
  • [47] Mechanisms responsible for cross-resistance and dichotomous resistance among the quinolones
    Sanders, CC
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 32 : S1 - S8
  • [48] SANDERS CC, 1990, FLUOROQUINOLONES TRE, P1
  • [49] SCHAEFFER AJ, 2002, AM J MED S1A, V113, P45
  • [50] Activity of quinolones against gram-positive cocci: Mechanisms of drug action and bacterial resistance
    Schmitz, FJ
    Higgins, PG
    Mayer, S
    Fluit, AC
    Dalhoff, A
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2002, 21 (09) : 647 - 659